A directions hearing in the dispute between Sigma Healthcare and Chemist Warehouse is set down for this Fri, as the companies continue to argue about whether Chemist Warehouse has the right to source generics from an alternative supplier.
Sigma confirmed the legal action last month (PD 25 May) warning of a possible annual impact of up to $10 million on its bottom line if Chemist Warehouse switches.
Since the dispute was revealed Sigma's shares have plummeted almost 30% from $1.19 prior to the announcement to trade at 84c yesterday.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Jun 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Jun 17
